453 related articles for article (PubMed ID: 32836201)
1. Development and validation of a nomogram for predicting survival of advanced breast cancer patients in China.
Lin S; Mo H; Li Y; Guan X; Chen Y; Wang Z; Yuan P; Wang J; Luo Y; Fan Y; Cai R; Li Q; Chen S; Zhang P; Li Q; Ma F; Xu B
Breast; 2020 Oct; 53():172-180. PubMed ID: 32836201
[TBL] [Abstract][Full Text] [Related]
2. Construction and validation of a nomogram to predict overall survival in patients with inflammatory breast cancer.
Diao JD; Ma LX; Sun MY; Wu CJ; Wang LJ; Liu YL; Yang YJ
Cancer Med; 2019 Sep; 8(12):5600-5608. PubMed ID: 31407527
[TBL] [Abstract][Full Text] [Related]
3. Development and validation of a nomogram for predicting survival of breast cancer patients with ipsilateral supraclavicular lymph node metastasis.
Lyu MH; Ma YZ; Tian PQ; Guo HH; Wang C; Liu ZZ; Chen XC
Chin Med J (Engl); 2021 Nov; 134(22):2692-2699. PubMed ID: 34743149
[TBL] [Abstract][Full Text] [Related]
4. Nomogram for Predicting the Overall Survival of Patients With Breast Cancer With Pathologic Nodal Status N3.
Wang J; Chen L; Nie Y; Wu W; Yao Y
Clin Breast Cancer; 2020 Dec; 20(6):e778-e785. PubMed ID: 32636150
[TBL] [Abstract][Full Text] [Related]
5. Nomogram-Predicted Survival of Breast Cancer Brain Metastasis: a SEER-Based Population Study.
Xiong Y; Cao H; Zhang Y; Pan Z; Dong S; Wang G; Wang F; Li X
World Neurosurg; 2019 Aug; 128():e823-e834. PubMed ID: 31096027
[TBL] [Abstract][Full Text] [Related]
6. Nomogram for predicting the overall survival of patients with inflammatory breast cancer: A SEER-based study.
Pan X; Yang W; Chen Y; Tong L; Li C; Li H
Breast; 2019 Oct; 47():56-61. PubMed ID: 31351202
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of Nomograms for predicting overall survival and Cancer-specific survival in patients with ovarian clear cell carcinoma.
Chen Q; Wang S; Lang JH
J Ovarian Res; 2020 Oct; 13(1):123. PubMed ID: 33069259
[TBL] [Abstract][Full Text] [Related]
8. Development and validation of a nomogram to predict overall survival for patients with metastatic renal cell carcinoma.
Zheng W; Zhu W; Yu S; Li K; Ding Y; Wu Q; Tang Q; Zhao Q; Lu C; Guo C
BMC Cancer; 2020 Nov; 20(1):1066. PubMed ID: 33148204
[TBL] [Abstract][Full Text] [Related]
9. Development and validation of nomogram combining serum biomarker for predicting survival in patients with resected rectal cancer.
Fan S; Li T; Zhou P; Peng Q; Zhu Y
Biosci Rep; 2019 Nov; 39(11):. PubMed ID: 31693739
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of a nomogram for predicting survival on the base of modified lymph node ratio in breast cancer patients.
Wen J; Yang Y; Liu P; Ye F; Tang H; Huang X; Zhong S; Xie X
Breast; 2017 Jun; 33():14-22. PubMed ID: 28259045
[TBL] [Abstract][Full Text] [Related]
11. Establishment of prognostic nomograms for predicting the progression free survival of EGFR-sensitizing mutation, advanced lung cancer patients treated with EGFR-TKIs.
Du X; Bai H; Wang Z; Daun J; Liu Z; Xu J; Chang G; Zhu Y; Wang J
Thorac Cancer; 2022 May; 13(9):1289-1298. PubMed ID: 35347870
[TBL] [Abstract][Full Text] [Related]
12. Establishment of Prognostic Nomograms for Predicting the Survival of HR-Positive, HER2-Negative Metastatic Breast Cancer Patients Treated with Everolimus.
Duan F; Song C; Ma Y; Jiang K; Xu F; Bi X; Huang J; Hong R; Huang Z; Lu Q; Yuan Z; Wang S; Xia W
Drug Des Devel Ther; 2021; 15():3463-3473. PubMed ID: 34408400
[TBL] [Abstract][Full Text] [Related]
13. Development and external validation of a nomogram predicting overall survival after curative resection of colon cancer.
Wang S; Liu Y; Shi Y; Guan J; Liu M; Wang W
J Int Med Res; 2021 May; 49(5):3000605211015023. PubMed ID: 33990147
[TBL] [Abstract][Full Text] [Related]
14. A Novel Prognostic Nomogram for Predicting Survival of Hormone Receptor-Positive and HER2 Negative Advanced Breast Cancer Among the Han-Population.
Zhu Y; Wang J; Xu B
Front Oncol; 2022; 12():918759. PubMed ID: 35847941
[TBL] [Abstract][Full Text] [Related]
15. Prediction of Minor Salivary Gland Carcinoma: A Novel Nomogram and Risk Classification System for Overall Survival and Cancer-Specific Survival.
Lan LF; Gao CK; Ma CW
Otolaryngol Head Neck Surg; 2021 Feb; 164(2):359-368. PubMed ID: 32692284
[TBL] [Abstract][Full Text] [Related]
16. Nomograms and risk classification systems predicting overall and cancer-specific survival in primary malignant cardiac tumor.
Guan T; Li Y; Qiu Z; Zhang Y; Lin W; Lai Y; Wang K; Shen Y; Du L; Liu C
J Card Surg; 2019 Dec; 34(12):1540-1549. PubMed ID: 31794125
[TBL] [Abstract][Full Text] [Related]
17. Development and validation of a nomogram to predict survival for advanced male breast cancer.
Zhang LP; Lin H; Wang AJ
Andrologia; 2022 Sep; 54(8):e14479. PubMed ID: 35618959
[TBL] [Abstract][Full Text] [Related]
18. Construction and Validation of a Nomogram for Predicting Progression- Free Survival in Patients with Early-Stage Testicular Germ Cell Tumor.
Chen JG; Wang JQ; Peng TW; Chen ZS; Zhao SC
Recent Pat Anticancer Drug Discov; 2021; 16(1):44-53. PubMed ID: 33573563
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of a nomogram for predicting cancer-specific survival of surgical resected stage I-II adenosquamous carcinoma of the lung.
Li H; Wang Z; Yang F; Wang J
J Surg Oncol; 2020 May; 121(6):1027-1035. PubMed ID: 32026478
[TBL] [Abstract][Full Text] [Related]
20. Development and validation of a nomogram predicting the overall survival of stage IV breast cancer patients.
Li S; Zhao J; Zhu L; Su F; Chen K
Cancer Med; 2017 Nov; 6(11):2586-2594. PubMed ID: 28980424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]